A Placebo-Controlled, Parallel-Group, Double-Blind, 12-Week Study to Assess the Clinical Efficacy, Safety, and Tolerability of L-000124467 in Rheumatoid Arthritis Patients
Latest Information Update: 10 May 2011
At a glance
- Drugs L 000124467 (Primary) ; Paracetamol
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 10 May 2011 New trial record